The FDA approves Orthofix Medical’s (NASDAQ:OFIX) STIM onTrack mobile app version 2.1 for use with its bone growth stimulators.
The app is designed to help patients adhere to their prescriptions and improve their clinical outcomes.
https://seekingalpha.com/news/3541677-fda-oks-new-version-of-orthofix-app-for-bone-growth-stimulators
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.